Melita Kaltak (ProQR Therapeutics NV) was selected as Poster Award Winner at the latest Oligonucleotide Therapeutics Society meeting for her work on an antisense oligonucleotide-mediated therapeutic approach for one of the most common Stargardt disease-causing variants in ABCA4. Very well done Melita!
At the recent European Society for Human Genetics meeting Eugenio Pugni from the Telethon Institute of Genetics and Medicine presented his latest work. In a collaboration with several other Italian institutions in the Naples area, he constructed a ABCA4 knock-out pig model which is currently being used to investigate and develop gene therapy options for Stargardt disease. Impressive work Eugenio!
Pietro de Angeli wins second prize in the ZEISS Presentation Award @ Young Researcher Vision Camp 2021
Our manuscript in which we unravel complex structural variants involving CEP78, using long-read sequencing, in patients with cone-rod dystrophy with hearing loss was provisionally accepted by Frontiers in Cell and Developmental Biology. Keep an eye on the official release date here.
The StarT consortium would like to participate in a fundraising activity 'StarT in action!' on the occasion of the International Day of Rare Diseases 2021 on February 28.
Everyone knows the unicorn, but no one has ever actually seen one. Unicorns only exist in a world of myth and fantasy. On the other hand, people with a rare disease do exist. And they are numerous… About 500,000 Belgians have a rare disease.
On the occasion of the International Day of Rare Diseases 2021 on February 28, we participate in the RadiOrg campaign “Not a Unicorn”. Because people with a rare disease are not unicorns. They really exist.
And you can help make them visible!
Sporty top athletes from UZ Gent and UGent will walk, run or cycle between 17 and 28 February 2021. They will be sponsored for this.
Would you like to sponsor our running, walking and cycling actions for 'StarT in action!' You can support StarT in action here:
Please spread the word via your social media! Follow us on Twitter @ITN_StarT and Instagram start_itn
Thank you in advance!
StarT fundraising team
Due to the passing of José Luis, Partner 6 (CSIC) of the ITN 813490-StarT project, a new PI has been designated: Dr. Juan R. Martinez-Morales, PhD, firstname.lastname@example.org. Juan closely collaborated with the Gómez-Skarmeta group for the last ten years. He has extensive experience in developmental biology including eye development, systems biology, and functional genomics.
Juan R. Martinez-Morales (ORCID 0000-0002-4650-4293) has led several projects related to eye diseases, supervised 4 completed PhD theses, has 40 publications, 1793 citations and has a H-index of 21. Juan will supervise Soraya Kalayanamontri (ESR2), together with co-supervisor Juan Tena and Ana Neto. A warm welcome to Juan!